AMAM
Ambrx Biopharma Inc
AMAM
AMAM
Delisted
AMAM was delisted on the 6th of March, 2024.
14 hedge funds and large institutions have $45.4M invested in Ambrx Biopharma Inc in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$70.4K | |
| 2 | -$30.6K | |
| 3 | -$20.2K | |
| 4 |
Morgan Stanley
New York
|
-$12K |
| 5 |
Millennium Management
New York
|
-$4.38K |